| 08/06/2026 4:00 PM | ProPhase Labs (868278) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 07/09/2026 2:12 PM | ProPhase Labs (868278) Filer | Form 10-Q/A | |
| 07/07/2026 8:23 AM | ProPhase Labs (868278) Filer | Form 10-Q/A | |
| 06/30/2026 3:50 PM | ProPhase Labs (868278) Filer | Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
| 06/01/2026 4:13 PM | ProPhase Labs (868278) Filer | Form 10-K Annual report pursuant to Section 13 or 15(d) | |
| 03/27/2026 4:10 PM | ProPhase Labs (868278) Filer | Form NT 10-K | |
| 01/27/2026 10:06 AM | ProPhase Labs (868278) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 01/23/2026 4:15 PM | ProPhase Labs (868278) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 01/23/2026 4:20 PM | ProPhase Labs (868278) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 01/23/2026 3:23 PM | Nasdaq Stock Market LLC (1354457) Filed by ProPhase Labs (868278) Subject | Form 25-NSE | |
| 01/09/2026 4:15 PM | ProPhase Labs (868278) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
Ready to give options a try? Your first trade (Ticker included) -INSIDE (Ad) Tired of trying tactic after tactic when it comes to options trades... only to be met with market noise and stinging losses? Dave Aquino is giving away the exact 11-hour options strategy he uses in volatile markets. You get the plain English blueprint behind the strategy and the very same "rinse and repeat" ticker he's traded nearly 900 times with a 95.3% success rate. It's so simple to understand, you could trade it tomorrow. Send me my free guide |
| 01/09/2026 4:10 PM | ProPhase Labs (868278) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 01/02/2026 4:10 PM | ProPhase Labs (868278) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 12/29/2025 4:04 PM | ProPhase Labs (868278) Filer | Form 424B5 | |
| 12/19/2025 2:37 PM | ProPhase Labs (868278) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 12/19/2025 12:03 PM | ProPhase Labs (868278) Filer | Form 424B5 | |
| 12/19/2025 12:07 PM | ProPhase Labs (868278) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 12/18/2025 12:30 PM | ProPhase Labs (868278) Filer | Form 8-K/A | |
| 12/12/2025 10:41 AM | ProPhase Labs (868278) Filer | Form 8-K/A | |
| 11/26/2025 1:15 PM | ProPhase Labs (868278) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 11/19/2025 3:06 PM | ProPhase Labs (868278) Filer | Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
| 11/19/2025 8:00 AM | ProPhase Labs (868278) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 11/10/2025 8:55 PM | Abenante Carolina (1965925) Reporting ProPhase Labs (868278) Issuer | Form 3 Initial statement of beneficial ownership of securities | |
| 10/31/2025 4:38 PM | ProPhase Labs (868278) Filer | Form DEF 14A | |
| 10/21/2025 4:29 PM | ProPhase Labs (868278) Filer | Form S-1 Registration statement under Securities Act of 1933 | |
| 10/21/2025 3:49 PM | ProPhase Labs (868278) Filer | Form PRE 14A | |
| 10/15/2025 4:22 PM | ProPhase Labs (868278) Filer | Form 424B5 | |
| 10/15/2025 1:15 PM | ProPhase Labs (868278) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 10/08/2025 9:20 AM | ProPhase Labs (868278) Filer | Form 424B3 | |
| 10/06/2025 5:05 AM | ProPhase Labs (868278) Filer | Form 424B3 | |